In 2023, there were 154 IPOs on the U.S. stock market. Here is a brief look at some of the worst-performing initial public offerings from last year.

Mira Pharmaceuticals made its public debut on the Nasdaq this week. The company raised $8.9 million in its IPO, which it intends to use towards accelerating toxicology and clinical research of its synthetic marijuana analog.